Pfizer, BioNTech Seek to Expand Covid Vaccine Use to Young Teens

Pfizer Inc. and its partner BioNTech SE said they would ask regulators in the U.S. and elsewhere to allow use of their Covid-19 vaccine in adolescents ages 12 to 15.
Read More